MCAReliefRx™: The Amazon of Merchant Lead Generation
Building the first compliance-driven Lead & Marketing Platform (LMP™) that transforms how capital providers connect with funding-ready SMB opportunities in the $800B alternative financing market.
Get Started
Executive Summary
MCAReliefRx™ is revolutionizing small business financing by building the first Lead & Marketing Platform (LMP™) — a compliance-first system that generates and delivers high-intent, funding-ready opportunities to vetted capital providers.
Unlike traditional ISOs or generic lead brokers, our LMP™ model is scalable, data-driven, and margin-rich. We're creating a defensible moat in a fragmented $800B market where billions are wasted on poor-quality leads and compliance risks.
We are raising up to $1.8M in seed financing to expand funnels, scale lender partnerships, and deploy technology — establishing MCAReliefRx™ as the #1 marketplace for alternative small business financing leads.
$1.8M
Seed Raise
Target funding amount
33M
SMB Market
U.S. small businesses
$800B
TAM Size
SMB financing market
Massive Market Opportunity
33M Small Businesses
U.S. market representing the backbone of American economy
~20% Seek Financing
Annually driving consistent demand for capital solutions
$25B MCA Volume
Annual merchant cash advance originations
$150B+ Working Capital
Demand for business loans and credit lines

Market Reality: Fragmented ecosystem with billions wasted on poor-quality leads and compliance risk. No dominant player delivering funding-ready, compliant opportunities — creating massive white space for disruption.
The Multi-Billion Dollar Problem
Merchants Face Predatory Terms
  • MCAs with 50-300% APR rates
  • Daily payment drafts destroying cash flow
  • Stacked loans creating debt spirals
  • Limited access to fair financing options
Banks Decline Most Applications
  • Rigid underwriting criteria exclude SMBs
  • Lengthy approval processes
  • Collateral requirements too restrictive
  • Credit score thresholds eliminate viable businesses
Funders Waste Capital on Bad Leads
  • Overpaying for low-quality, unqualified prospects
  • Constant TCPA and compliance exposure
  • Poor conversion rates drain marketing budgets
  • No standardized qualification process
The LMP™ Solution: Four Revenue Streams
MCAReliefRx™ transforms the market with our proprietary Lead & Marketing Platform (LMP™) — a compliance-first system that creates multiple monetization opportunities while delivering superior value to all stakeholders.
Lead Sales (CPL)
Raw Leads: $50-90 per qualified contact
Warm/Doc-Ready: $200-500 per funding-ready prospect
Marketing Rev-Share
3-8% of funded volume with select capital partners
Aligned incentives drive long-term relationships
Compliance Advantage
TCPA, TSR, CAN-SPAM aligned processes
Built-in regulatory protection reduces liability
Future SaaS Platform
AI scoring algorithms and lender dashboards
Compliance logs and automated reporting
The LMP™ Flywheel: Defensible Growth Engine
01
Acquire
Multi-channel inbound funnels and proprietary acquisition strategies drive consistent lead flow from qualified merchants seeking capital solutions.
02
Qualify
Compliance-first screening with in-house team verification ensures only funding-ready prospects enter our marketplace, reducing waste for capital providers.
03
Monetize
Dual revenue streams through CPL lead sales and revenue sharing arrangements create sustainable, scalable income from each qualified opportunity.
04
Scale
Proven model expands across MCA, debt relief, tax resolution, legal services, and healthcare finance verticals for exponential growth.
Business Model & Competitive Advantage
Revenue Model
  • Lead Sales (CPL): $50-90 raw, $200-500 warm/doc-ready
  • Marketing Rev-Share: 3-8% of funded volume
  • Future SaaS: Lender subscriptions for compliance dashboards
  • Target Margins: 60-70% gross margin potential
Market Position
We're creating an entirely new category — the Lead & Marketing Platform (LMP™) — that combines the best of traditional lead generation with compliance-first operations and technology-driven scalability.
Experienced Leadership Team
David Plante - CEO
15+ years in finance and fintech with proven track record. Former operations lead at $1B+ debt resolution firm, bringing deep industry expertise and regulatory knowledge to drive strategic growth.
David Lam - COO
25+ years in financial management, real estate, and commercial capital. Extensive operational experience in scaling financial services businesses and managing complex lending partnerships.
Compliance Advisor
Former regulator with specialized expertise in debt relief and SMB lending oversight. Ensures our platform maintains the highest standards of regulatory compliance and risk management.
Advisory Board
Specialists in marketing, compliance, and capital markets providing strategic guidance. Industry veterans with combined decades of experience in fintech, lending, and regulatory environments.
Financial Projections & Sensitivity Analysis
Revenue Growth Outlook
Projections are illustrative, based on industry benchmarks. Actual results may differ significantly.
CPL Sensitivity Analysis

Even under conservative assumptions, margins remain healthy at 55%. Upside scenarios highlight the exceptional scalability potential of the LMP™ model.
Investment Opportunity & Vision
Investment Terms
  • Raise: Up to $1.8M seed financing
  • Instrument: SAFE or Convertible Note
  • Valuation: To be determined with lead investor
  • Minimum Investment: $50K
  • Eligible Investors: Accredited only (Reg D)
Exit Strategy
  • Strategic Acquirers: LendingTree, NerdWallet, Credit Karma, Nav
  • Industry Consolidation: OnDeck, Fora, Kapitus
  • IPO Potential: If scaled into dominant multi-vertical LMP™
"By 2030, MCAReliefRx™ will be recognized as the Amazon of Lead & Marketing Platforms (LMP™) — powering MCA relief, debt relief, tax resolution, legal services, and healthcare finance."
We're not building another ISO. We're creating the category-defining LMP™ — a scalable platform that will transform how financial services connect with consumers across multiple industries.
This presentation is for informational purposes only and does not constitute an offer to sell or solicitation to buy securities. Projections are illustrative and subject to risks and uncertainties. Please refer to the Company's Private Placement Memorandum for full disclosures.